Tenderwize
Wróć do wyszukiwania

Pharmaceutical rebate agreements with accession option

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline Nov 01, 2027 · 431 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisać
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittelrabattverträge mit Beitrittsoption

20/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

20 / 100

Złożoność

45 / 100

Czynniki ryzyka

No estimated value, award criteria, or eligibility criteria are provided. This makes it impossible to assess the tender...

The notice states it is not a public procurement under EU Directive 2014/24/EU, yet it uses the open procedure label. T...

No procurement documents available

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 2 lots
  • Duration until Dec 2027
  • Supply of pharmaceutical products containing Aflibercept 40 mg/ml in two forms: vials (Durchstechflaschen) and pre-filled syringes (Fertigspritzen).
  • Framework agreement with accession option (Beitrittsoption) allowing additional parties to join.
Pokaż pełne podsumowanie

This is a German framework agreement with accession option for pharmaceutical products (Aflibercept) issued by BARMER Beschaffung und Vergabe. It consists of two lots: one for vials (40 mg/ml) and one for pre-filled syringes (40 mg/ml). The notice explicitly states it is not a public procurement under EU directives, but uses an open procedure format. No estimated values, award criteria, or eligibility criteria are provided. The submission deadline is November 1, 2027, with a two-year contract period starting December 1, 2025. The buyer is a health insurance body. The tender is available only electronically via the buyer's platform. Documents were not analyzed beyond the XML notice.

Ryzyka

No estimated value, award criteria, or eligibility criteria are provided. This makes it impossible to assess the tender...

The notice states it is not a public procurement under EU Directive 2014/24/EU, yet it uses the open procedure label. T...

No procurement documents available

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Maximum of 2 lots can be awarded to one tenderer (MaximumLotsAwardedNumeric: 2).
  • Variants are not allowed.

Administrative

  • Tenders must be submitted electronically via the buyer's platform (Otwórz portal).

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

Wuppertal, DEU

Identyfikator

992-80322-57

Działalność

Health

Części (2)

LOT-0001

Aflibercept (Vials 40 mg/ml)

Supply of medicinal products containing Aflibercept in vial form (40 mg/ml). Framework agreement with accession option.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Wuppertal, Germany

Czas trwania

Nov 2025 - Dec 2027

Kategoria

Pharmaceutical products

Termin

Deadline Nov 01, 2027

LOT-0002

Aflibercept (Pre-filled Syringes 40 mg/ml)

Supply of medicinal products containing Aflibercept in pre-filled syringe form (40 mg/ml). Framework agreement with accession option.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Wuppertal, Germany

Czas trwania

Nov 2025 - Dec 2027

Kategoria

Pharmaceutical products

Termin

Deadline Nov 01, 2027

Szczegóły zamówienia

Data publikacji
20 Oct 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
692194-2025

Dokumenty (1)

Portal składania ofert 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3